Healthcare Experience


Our Healthcare experience includes 848 clients, with 43 partnered brands and 817 USAN/INN names. Below is our extensive portfolio, feel free to filter by clients, brands, category or USAN/INN Names.   ||  Click Here for Consumer/B2B Experience



CLIENTS BRANDS CATEGORY
FOREST LABORATORIES TEFLARO Antibiotic
FOREST LABORATORIES AVYCAZ Antibiotic
FERRER INTERNACIONAL OZANEX * Antibiotic
FERRER INTERNACIONAL TRINOMIA Cardiovascular
FOREST LABORATORIES BYSTOLIC * Cardiovascular
FERRING PHARMACEUTICALS SEPSIS-ACT Clinical Trial Name
FORBES MEDI-TECH FORBES MEDI-TECH Corporate Identity
FOREST LABORATORIES LINZESS Gastrointestinal
FERRING PHARMACEUTICALS PREPOPIK Gastrointestinal
FERRING PHARMACEUTICALS CORTIMENT * Gastrointestinal
FOREST LABORATORIES CONSTELLA * Gastrointestinal
FIBROGEN pamrevlumab Immunology
FERRING PHARMACEUTICALS olamkicept Immunology
FREEDOM INNOVATIONS KINTERRA Medical Device
FERX MAGNETARG Medical Device
Ferring PHARMACEUTICALS apraglutide Metabolic Disorders
FERRING PHARMACEUTICALS NOCDURNA Nephrology
FIBROGEN roxadustat Nephrology
FRESENIUS PHOSLYRA * Nephrology
FABRE KRAMER PHARMACEUTICALS TRAVIVO Neurology
FOREST LABORATORIES CAMPRAL Neurology
FOREST LABORATORIES CELEXA Neurology
FOREST LABORATORIES NAMENDA Neurology
FOREST LABORATORIES NAMENDA XR Neurology
FORUM PHARMACEUTICALS encenicline Neurology
FOREST LABORATORIES NAMZARIC Neurology
FOREST LABORATORIES VIIBRYD * Neurology
FGK REPRESENTATIVE SERVICE DZUVEO Neurology
Flex Pharma enexasogaol Neurology
FRESENIUS-KABI KABIVEN Nutritional Agent
FIVE PRIME THERAPEUTICS cabiralizumab Oncology
FORTY SEVEN magrolimab Oncology
FIVE PRIME THERAPEUTICS bemarituzumab Oncology
FERA PHARMACEUTICALS AVACLYR * Ophthalmology
FLEXION THERAPEUTICS ZILRETTA * Pain & Inflammation
FOREST LABORATORIES DALIRESP Respiratory
FAMY CARE ESME 21 Women's Health
FAMY CARE ESME 28 Women's Health
FOREST LABORATORIES SAVELLA Women's Health
FERRING PHARMACEUTICALS merotocin Women's Health
FERRING PHARMACEUTICALS follitropin delta Women's Health
FAMY CARE INDAYO Women's Health
FAMY CARE CONTINGENCY ONE Women's Health


* Denotes a comprehensive report of the safety regulatory research prepared by BI/DSI for submission of this name candidate to FDA, EMA, Health Canada, JMHLW, ANVISA, ROSZDRAVNADZOR, CDSCO, CFDA, KOREA MFDS, and/or other Regulatory Agencies.

Back to top